Biomarker-defined endotypes of pulmonary fibrosis

被引：0
|
作者：
MCcall, A. Scott [1 ,2 ]
Kropski, Jonathan A. [1 ,2 ,3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA
[2] Dept Vet Affairs, Med Ctr, Nashville, TN 37212 USA
[3] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA
来源：
LANCET RESPIRATORY MEDICINE | 2024年 / 12卷 / 09期
关键词：
SURVIVAL;
D O I：
10.1016/S2213-2600(24)00169-3
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：657 / 659
页数：3
相关论文
共 50 条
  • [1] Imaging and Circulating Biomarker-Defined Cardiac Pathology in Pulmonary Tuberculosis: A Systematic Review
    Scopazzini, Marcello S.
    Hill, Katherine J.
    Majonga, Edith D.
    Zenner, Dominik
    Ayles, Helen
    Shah, Anoop S. V.
    GLOBAL HEART, 2024, 19 (01)
  • [2] Cued memory decline in biomarker-defined preclinical Alzheimer disease
    Papp, Kathryn V.
    Rentz, Dorene M.
    Mormino, Elizabeth C.
    Schultz, Aaron P.
    Amariglio, Rebecca E.
    Quiroz, Yakeel
    Johnson, Keith A.
    Sperling, Reisa A.
    NEUROLOGY, 2017, 88 (15) : 1431 - 1438
  • [3] Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
    Boyiadzis, Michael M.
    Kirkwood, John M.
    Marshall, John L.
    Pritchard, Colin C.
    Azad, Nilofer S.
    Gulley, James L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [4] Subclinical acute kidney injury: a novel biomarker-defined syndrome
    Bagshaw, Sean M.
    CRITICAL CARE AND RESUSCITATION, 2011, 13 (03) : 201 - 203
  • [5] Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
    Price, D.
    Burkill, S.
    Wang, E.
    Wechsler, M. E.
    Denton, E.
    Tran, T. N.
    Martin, N.
    Katial, R.
    Barker, P.
    Maspero, J.
    Hew, M.
    Bruselle, G.
    Christoff, G. C.
    Sadatsafavi, M.
    Torres-Duque, C. A.
    Porsbjerg, C. M.
    Ulrik, C.
    Hansen, S.
    Altraja, A.
    Bourdin, A.
    Papadopoulos, N. G.
    Kostikas, K.
    Salvi, S.
    Costello, R. W.
    Francesca, P.
    Iwanga, T.
    Rhee, C. Kook
    Al-Ahmad, M.
    Linnemann, D. Larenas
    Fonseca, J. A.
    Cosio, B. G.
    Siyue, M. Koh
    Kirenga, B.
    Sheu, C.
    Tsai, M.
    Mahboub, B.
    Busby, J.
    Heaney, L. G.
    Pfeffer, P. E.
    Patel, P.
    Hoyte, F.
    Liu, Y.
    Goh, C.
    Lyu, J.
    Uthaman, T.
    Henley, W.
    Henley, W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Spatial navigation and scene exploration in biomarker-defined early Alzheimer's disease
    Parizkova, M.
    Kalinova, J.
    Vyhnalek, M.
    Hort, J.
    Wiener, J.
    Laczo, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 296 - 296
  • [7] Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States
    Iorgulescu, J. Bryan
    Sun, Chuxuan
    Neff, Corey
    Cioffi, Gino
    Gutierrez, Catherine
    Kruchko, Carol
    Ruhl, Jennifer
    Waite, Kristin A.
    Negoita, Serban
    Hofferkamp, Jim
    Tihan, Tarik
    McLendon, Roger
    Brat, Daniel J.
    Ostrom, Quinn T.
    Barnholtz-Sloan, Jill S.
    NEURO-ONCOLOGY, 2022, 24 (11) : 1989 - 2000
  • [8] Deep learning augmented ECG analysis to identify biomarker-defined myocardial injury
    Gunvant R. Chaudhari
    Jacob J. Mayfield
    Joshua P. Barrios
    Sean Abreau
    Robert Avram
    Jeffrey E. Olgin
    Geoffrey H. Tison
    Scientific Reports, 13
  • [9] Deep learning augmented ECG analysis to identify biomarker-defined myocardial injury
    Chaudhari, Gunvant R.
    Mayfield, Jacob J.
    Barrios, Joshua P.
    Abreau, Sean
    Avram, Robert
    Olgin, Jeffrey E.
    Tison, Geoffrey H.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect
    Jiang, Wenyu
    Freidlin, Boris
    Simon, Richard
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (13) : 1036 - 1043
12345